Table 2.

Proportion of physicians who identified treatments considered effective in improving HFpEF outcomes

	PCPs (n = 200)	Internists (n = 89)	Cardiologists (n = 159)	P, across 3 groups	P, specialists vs PCPs
ACE inhibitors	48.0%	24.7%	6.9%	< 0.001	< 0.001
ARB	39.0%	24.7%	17.6%	< 0.001	< 0.001
β-Blockers	42.0%	18.0%	13.2%	< 0.001	< 0.001
Loop diuretics	28.5%	18.0%	15.7%	< 0.001	< 0.001
MRA	31.0%	27.0%	37.7%	< 0.001	< 0.001
All of the above	57.0%	14.6%	11.3%	< 0.001	< 0.001
None of the above	9.0%	41.6%	48.4%	< 0.001	< 0.001

ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; HFpEF, heart failure with preserved ejection fraction; MRA, mineralocorticoid receptor antagonists; PCPs, primary care physicians.